Intangible Assets |
12 Months Ended |
|---|---|
Jan. 31, 2026 | |
| Intangible Assets | |
| Intangible Assets | 4. Intangible Assets
The Company is currently developing several drug candidates and holds a portfolio of patents related to them. The relevant intangible assets have been fully impaired in prior years and currently are recorded at carrying values of $nil. |